Agios Pharm (AGIO) — Strategic Asset Allocation Index
Agios Pharm (AGIO) has a Strategic Asset Allocation Index of 26.0% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $310.01 Million) total $310.01 Million, measured against net assets of $1.19 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Agios Pharm Strategic Asset Allocation Index (2011–2025)
This chart shows how Agios Pharm's Strategic Asset Allocation Index has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the index stands at 26.0%, representing strategic assets of $310.01 Million against net assets of $1.19 Billion USD. Explore Agios Pharm cash conversion from operations to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Agios Pharm (2011–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Agios Pharm from 2011 to 2025, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see AGIO market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 26.0% | $310.01 Million | $- | $310.01 Million | $1.19 Billion | ▼ -15.4 pp |
| 2024 | 41.4% | $638.32 Million | $- | $638.32 Million | $1.54 Billion | ▲ +37.8 pp |
| 2023 | 3.6% | $29.43 Million | $- | $29.43 Million | $811.02 Million | ▼ -27.0 pp |
| 2022 | 30.6% | $336.86 Million | $22.99 Million | $313.87 Million | $1.10 Billion | ▲ +7.7 pp |
| 2021 | 22.9% | $295.30 Million | $28.92 Million | $266.38 Million | $1.29 Billion | ▼ -9.7 pp |
| 2020 | 32.5% | $129.90 Million | $32.29 Million | $97.61 Million | $399.50 Million | ▲ +3.7 pp |
| 2019 | 28.8% | $184.40 Million | $31.47 Million | $152.93 Million | $640.53 Million | ▼ -6.8 pp |
| 2018 | 35.6% | $244.44 Million | $24.32 Million | $220.12 Million | $687.54 Million | ▼ -9.3 pp |
| 2017 | 44.8% | $168.25 Million | $24.43 Million | $143.81 Million | $375.50 Million | ▲ +28.7 pp |
| 2016 | 16.1% | $57.59 Million | $25.34 Million | $32.25 Million | $358.59 Million | ▼ -7.7 pp |
| 2015 | 23.8% | $82.12 Million | $23.22 Million | $58.91 Million | $345.12 Million | ▼ -7.3 pp |
| 2014 | 31.1% | $131.77 Million | $6.39 Million | $125.38 Million | $424.37 Million | ▲ +7.6 pp |
| 2013 | 23.5% | $30.88 Million | $3.76 Million | $27.12 Million | $131.48 Million | ▲ +15.4 pp |
| 2012 | 8.1% | $3.56 Million | $3.56 Million | $- | $43.90 Million | ▲ +3.0 pp |
| 2011 | 5.1% | $3.22 Million | $3.22 Million | $- | $63.14 Million | — |